Related Experiment Video
Updated: Mar 1, 2026

Surgical Correction for Pediatric Epiblepharon and Trichiasis
Published on: July 8, 2025
Pilonidal sinus disease surgery in children: the first study to compare crystallized phenol application to primary
Ufuk Ates1, Ergun Ergun1, Gulnur Gollu1
1Ankara University Faculty of Medicine, Department of Pediatric Surgery, Ankara, Turkey.
Insights
Crystallized phenol application is a feasible, minimally invasive treatment for pediatric pilonidal sinus (PS), showing lower recurrence and complication rates compared to traditional excision and primary closure.
Area of Science:
- Pediatric Surgery
- Dermatology
- Wound Healing
Background:
- Pilonidal sinus (PS) is a common infectious and inflammatory condition affecting the sacrococcygeal region.
- Current treatment options for PS include surgical excision, flap procedures, and chemical applications.
- The optimal treatment for pediatric PS remains a subject of ongoing research.
Purpose of the Study:
- To compare the efficacy and outcomes of crystallized phenol application versus excision and primary closure for treating pediatric pilonidal sinus.
- To evaluate recurrence and complication rates associated with each treatment modality.
Main Methods:
- Retrospective analysis of medical data from pediatric patients diagnosed with pilonidal sinus.
- Patients were treated with either excision and primary closure (77 patients) or crystallized phenol application (40 patients).
- Data on hospitalization time, follow-up duration, recurrence, and complications were analyzed.
Main Results:
- The study included 117 pediatric patients with PS (52 girls, 65 boys; mean age 15.6 years).
- Patients treated with phenol had shorter hospital stays (discharged same day) compared to excision and primary closure (mean 2.7 days).
- Phenol group had a mean follow-up of 8.1 months, while excision group had 44.6 months, with phenol showing lower recurrence and complication rates.
Conclusions:
- Crystallized phenol application presents a feasible, minimally invasive alternative for pediatric PS treatment.
- This method appears to offer lower recurrence and complication rates compared to traditional excision and primary closure.
- Further research is warranted to establish the long-term efficacy of phenol application in pediatric PS management.
Introduction:
Pilonidal sinus (PS) is an infectious and inflammatory disease of sacrococcygeal region. Current methods include; surgical excision with/without suturing the defect, rhomboid excision and flap and chemical substance application. In this study, crystallized phenol application was compared to excision and primary closure.
Patients And Methods:
This retrospective study included pediatric patients with PS who were treated with excision and primer closure technique and phenol application. The patients' medical data were analyzed retrospectively.
Results:
This study included 117 patients with PS. There were 52 girls (44%) and 65 boys (56%). Mean age of children was 15.6 (12-20) years. Excision and primary closure were applied to 77 patients (66%) and phenol was applied to 40 patients (34%). The children in phenol group were discharged on the operation day; mean hospitalization time in the excision and primary closure group was 2.7 (1-14) days. Mean follow up was 44.6 (8-82) months for primary excision and closure group and 8.1 (1-19) months for phenol group.
Conclusion:
Although many surgical and non-surgical treatment modalities have been described for PS, the optimal one remains unknown. Limited with the retrospective nature of the data, crystallized phenol application seems a feasible minimal invasive alternative to primary closure of PS with lower recurrence and complication rates in children.
Treatment Study:
Level III.
More Related Videos
07:30Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
06:13Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018